| 2.07 Basic research is short of funds The pharmaceutical industry accounts for a third of all industrial research and development activities in Denmark, which makes it the most innovative sector in the country’s economy. The greater part of the research effort takes place within individual companies. However, an increasing amount of research is being carried out as collaborations between various partners, including university research programmes. For the pharmaceutical industry, it is particularly important that hospitals have sufficient research funding. Here, research must be seen as a prerequisite for the ability to continually improve treatment. Collaboration between the industry and public research establishments ought therefore to be further expanded, while the state should promote opportunities for collaboration by allocating more funds to relevant public research establishments. It must be ensured that publicly funded basic research is independent of special interests. It is therefore important to ensure that there are clear rules governing the use of the results produced by such research. But an innovation is no good to anyone if it is not put to use. Therefore increased incentives ought to be created for the public sector to exploit the results of research in partnership with private-sector companies. That would enhance the companies’ competitiveness and ensure that society gained from the research results. Lif believes:
|